Bimekizumab
ATC L04AC21 · 9 markets · 27 records
AU 7 records · 4 strengths
- 320 mg/2 mLinjectionBimzelx
- 160 mg/1 mLinjectionBimzelx
- 160 mg/mLinjectionBIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injectorBIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe
Records without a stated strength · 1 Bimzelx
US 4 records · 2 strengths
GB 4 records · 2 strengths
- 320 mg/2 mLinjectionBimzelx 160mg/1ml solution for injection pre-filled pensBimzelx 160mg/1ml solution for injection pre-filled syringes
- 160 mg/1 mLinjectionBimzelx 160mg/1ml solution for injection pre-filled pensBimzelx 160mg/1ml solution for injection pre-filled syringes
CA 4 records · 2 strengths
ES 3 records · 2 strengths
- 160 mginjectionBIMZELX PRECARGADA
- 320 mginjectionBIMZELX PRECARGADA
HK 2 records · 1 strengths
Records without a stated strength · 1 BIMZELX SOLUTION FOR INJECTION IN PRE-FILLED PEN 160MG/ML
MX 1 records · 1 strengths
Records without a stated strength · 1 Bimzelx
TW 1 records · 1 strengths
- 160 mginjectionBimzelx Solution for Injection 160 mg/ml本能適注射液160毫克/毫升
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 Bimzelx
| Strength / form / release | US | GB | CA | AU | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 320 mg/2 mL injection | Bimzelx | Bimzelx 160mg/1ml solution for injection pre-filled pens Bimzelx 160mg/1ml solution for injection pre-filled syringes | Bimzelx | ||||||
| 160 mg injection | Bimzelx | BIMZELX PRECARGADA | Bimzelx Solution for Injection 160 mg/ml 本能適注射液160毫克/毫升 | ||||||
| 160 mg/1 mL injection | Bimzelx 160mg/1ml solution for injection pre-filled pens Bimzelx 160mg/1ml solution for injection pre-filled syringes | Bimzelx | |||||||
| 160 mg/mL injection | BIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injector BIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe | ||||||||
| 160 mg liquid | Bimzelx | ||||||||
| 160 mg/1 mL liquid | Bimzelx | ||||||||
| 320 mg injection | BIMZELX PRECARGADA | ||||||||
unknown | Bimzelx | BIMZELX SOLUTION FOR INJECTION IN PRE-FILLED PEN 160MG/ML | Bimzelx | ||||||
liquid | Bimzelx |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in CA · ES · MX and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · ES · MX que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · ES · MX 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 CA · ES · MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.